U.S. flag

An official website of the United States government

GTR Home > Tests > Chromosome Analysis, Tissue (Postnatal, POC, or Autopsy)

Laboratory contact

Laboratory information

Help

Institute for Genomic Medicine (IGM) Clinical Laboratory, ChildLab, IGM
Nationwide Children's Hospital

Laboratory director(s)

Help
  • Yassmine Akkari, PhD, FACMG, Lab Director
  • Melanie Babcock, PhD, FACMG, Lab Director
  • Catherine Cottrell, PhD, FACMG, Lab Director
  • Ying-Chen (Claire) Hou, PhD, Lab Director
  • Jesse Hunter, PhD, FACMG, Lab Director
  • Marco Leung, PhD, FACMG, Lab Director
  • Mariam Mathew, PhD, FACMG, Lab Director
  • Hui Mei, PhD, FACMG, Lab Director
  • Shalini Reshmi, PhD, FACMG, Lab Director
  • Kathleen Schieffer, PhD, FACMG, Lab Director

Laboratory contact

Help
  • Institute for Genomic Medicine (IGM)
  • 700 Children's Drive
  • Columbus, Ohio 43205
  • United States

Laboratory affiliations

Help

Laboratory services offered

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Confirmation of research findings
  • Maternal cell contamination study (MCC)
  • Mutation Confirmation

Laboratory credentials

CLIA certification

Help
  • Number: 36D0665271, Expiration: 2023-02-08
  • Number: 36D2131848, Expiration: 2024-11-27

Certifications

Help
  • CAP, Number: 1637201, Expiration: 2024-11-15
  • CAP, Number: 8162772, Expiration: 2024-11-15

Practice guidelines

  • ACMG, 2021
    Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
  • NSGC, 2021
    National Society of Genetic Counselors Position Statement: Prenatal Cell-Free DNA Screening
  • ACMG, 2016
    Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics
  • ESHG/ASHG, 2015
    Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
  • NSGC, 2013
    Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. (Replaced by NSCG, 2021 Statement)
  • ACMG, 2013
    ACMG statement on noninvasive prenatal screening for fetal aneuploidy. (See 2016 Update)
  • ICFMM, 2013
    Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing.
  • NSGC, 2013
    NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.